Antigen Binding Articles & Analysis
2 news found
Antibodies (immunoglobulins) are a key component of the mammalian immune response and are increasingly of interest as a means of therapy for several diseases. In fact, there are over 100 monoclonal antibodies that have been approved as drugs1. Despite this apparent success, there are issues with biopharmaceutical antibody research and development – not least the cost of goods. Although it ...
IntoCell, a South Korean biotech developing novel antibody drug conjugate (ADC) platform technologies, today announced the signing of a research collaboration with Ab Studio, a US biotech focused on the discovery of novel antibodies. The collaboration will include construction of a panel of ADCs by integrating IntoCell's proprietary payloads and Ortho-Hydroxy Protected Aryl Sulfate (OHPAS) ...